ARTICLE | Clinical News
Enzon, Santaris preclinical data
November 23, 2009 8:00 AM UTC
EZN-3892 and EZN-3889 each significantly down-modulated beta-catenin mRNA and protein in multiple tumor cell lines and in mouse models of liver cancer. Data were presented at the AACR-NCI-EORTC Inter...